Implementing AI to predict interval cancers in a national screening program

Conclusion: Transpara has the potential to reduce the stable high rate of interval cancer in case it is applied as a second or third independent reader within a national breast cancer screening program. Moreover, further developments of AI promise increasing performance towards the prediction of interval cancer.